BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Procognia Limited Announces Receipt of cGMP Certificate for Its Glycosylation Analysis Services


9/3/2013 8:39:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

August 29, 2013 -- Procognia, a biotechnology company providing analytical services to the biopharmaceutical and biosimilar industry, announced today receipt of a current Good Manufacturing Practice (cGMP) compliance certification for its glycosylation analysis services.

Procognia’s laboratories in Rehovot, Israel successfully passed a cGMP inspection held by the Israeli Ministry of Health, a member of the European PIC/s, the Pharmaceutical Co-operation Inspection organization. The inspection concluded that the services provided by Procognia comply with cGMP requirements referred to in the Conformity Assessment and Acceptance of Industrial Products (CAA) Agreement between the European Union, and the Israeli law and regulations.

Mrs. Larisa Amir, COO at Procognia says: “Our customers benefit from our high standards and quality management system. This cGMP certification, standard, ensure that Procognia’s services meet the high quality international standards required by the pharmaceutical industry”.

The cGMP compliance certificate is granted to Procognia for its biologics carbohydrate analysis services provided to biopharmaceutical and biosimilar developers and manufacturers. Procognia provides glycosylation analysis services using various methods including HPLC-based methods and Procognia’s proprietary high throughput glycosylation screening tool, the GlycoScopeTM.

Dr. Ruth Ben Yakar, Procognia’s CEO stated: “We are proud to offer our customers analytical services at the highest industry standards. This approval enables us to expand our services to in-process manufacturing control, product release, and stability testing, in addition to the services we provide for product development stages”.

About Procognia

Procognia (Israel), established in 2000, is a leader in glycobiology and biopharmaceutical analytics. Procognia offers services and solutions to major challenges in biopharmaceutical and biosimilar development and manufacturing, including comprehensive analytical services and access to a large database of glycosylation profiles of biosimilar references for achievement of optimal glycosylation profiles for improved efficacy, safety and biosimilarity.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES